NEWwbztv-small wbz-am-small 985-small mytv38web2

Local

NH Sen. Ayotte Urges FDA To Allow Experimental Drug To Help Local Girl

View Comments
McKenzie Lowe (Change.org)

McKenzie Lowe (Change.org)

Get Breaking News First

Receive News, Politics, and Entertainment Headlines Each Morning.
Sign Up

HUDSON, N.H. (CBS) — A New Hampshire politician is stepping up to help a local girl receive the medicine she needs to fight an inoperable brain tumor.

U.S. Senator Kelly Ayotte is urging the Food and Drug Administration to allow a 12-year-old McKenzie Lowe to continue an experimental treatment through the FDA’s compassionate use program.

Last year, Lowe was diagnosed with Diffuse Intrinsic Pontine Glioma and was given a zero percent chance of survival, but she has fought the disease for a year. Her family says that’s thanks to this experimental drug not approved by the FDA.

They believe the drug therapy, spearheaded by a doctor in Texas, could be her best chance at survival.

The Lowes recently started a petition, which has been signed by Senator Ayotte and more than 41,000 people, asking the FDA to grant McKenzie an exemption.

Related: Petition To FDA

“The Lowes are fighting for their terminally-ill little girl and they deserve the right to explore treatment options that may help her continue to fight her cancer,” Ayotte wrote in a letter  to the FDA Commissioner. “Whether or not a terminally-ill child is able to receive certain types of care should be a decision made by the family. I would hope the FDA would not stand in the way when no other treatment options are available for an already terminally-ill child.”

There’s no word yet on a response from the FDA.

MORE LOCAL NEWS FROM CBS BOSTON
View Comments
blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 2,046 other followers